Search
for
Sort by
Research 61–90 of 1000+
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Polycystic ovary syndrome
- Pharmacology of anabolic steroids
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Sulfatase inhibitors: a patent review
- 11 Treatment of hirsutism and acne with cyproterone acetate
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Hormone therapy in acne
- Androgen Treatment in Adolescent Males With Hypogonadism
- Relations between sex hormone level and characters of hair and skin in healthy young men
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Mitochondria Dysfunction and Inflammation in Traumatic Brain Injury: Androgens to the Battlefront
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Testosterone Treatment in Women – An Overview
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Obesity and female androgenic alopecia: A cause and an effect?
- Endocrine disorders and hormonal therapy for adolescent acne
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Steroid Hormones